|
IMDS, MBDE, DMED, EFIR, GRDO, DGRI
Our Stocks to Watch today include Imaging Diagnostic Systems Inc. (OTCBB: IMDS), Morris Business Development Company Inc. (OTCBB: MBDE), D. Medical Industries Ltd. (NASDAQ: DMED), EGPI Firecreek Inc. (OTCBB: EFIR), Guard Dog Inc. (OTC: GRDO) and Dutch Gold Resources Inc. (OTC: DGRI).
IMAGING DIAGNOSTIC SYSTEMS (OTCBB: IMDS)
"Up 133.33% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/IMDS.php
Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM® system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM®) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485. The Company is seeking FDA approval through the Premarket approval process.
IMDS News:
May 14 - Imaging Diagnostic Signs Shimadzu Medical to Market Its CTLM® Laser Breast Imaging Device in Australia, New Zealand and the Pacific Islands
Imaging Diagnostic Systems, Inc. (OTCBB: IMDS), a pioneer in laser breast imaging, announced today that it has signed a distribution agreement with Shimadzu Medical to market and sell its Computed Tomography Laser Mammography (CTLM®) System in Australia, New Zealand and the Pacific Islands.
"This strategic move follows in line with our vision to be in the forefront of innovative technologies that will further enhance our business. The Directors of Shimadzu Corporation unanimously agreed that the CTLM® system could heighten our image in the breast imaging realm. IDSI has developed a high quality innovative breast imaging product that will expand our product range. Shimadzu is well positioned to provide ongoing sales, service and support for the CTLM given our history and expertise in the medical device arena. We are excited to make this innovative technology available to women in Australia, New Zealand and the Pacific Islands," commented Nick Mascoulis, General Manager/Shimadzu Medical Systems (Oceania) P/L.
Shimadzu Medical Systems (Oceania) Pty Ltd is an Australasian subsidiary of Shimadzu Corporation, Kyoto, Japan. Shimadzu's goal is to support a healthy, comfortable living for all people. They have strived to contribute to people's health and well-being since their inception in 1875. Shimadzu focuses on the development of "molecular imaging technology" to enable detection of subtle symptoms before the onset of full-blown diseases.
Linda Grable, CEO of Imaging Diagnostic Systems, Inc., states, "IDSI is very excited to appoint Shimadzu Corporation, a leader of global technologies, as the distributor in Australia, New Zealand and the Pacific Islands. We are eager to work with Shimadzu to make CTLM® available to women in that part of the globe."
MORRIS BUSINESS DEVELOPMENT COMPANY (OTCBB: MBDE)
"Up 2,369.95% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/MBDE.php
Morris Business Development Company provides services for the development and growth of American public and private stock companies primarily in the United States. The company offers a range of consulting services to its portfolio company clients, such as debt and equity financing, strategic business plan development, and productive assets; management personnel and other resource acquisition, including licensing, partnering, distributor, and joint venture relationships; preparation for growth funding and financial restructuring; preparation and guidance for going public and remaining a compliant public company; investor exposure and market trading support; exit strategy with tax planning; and professional and life coaching. It also provides services for the duplication, replication, and packaging of DVDs and CDs. The company was formerly known as Electronic Media Central Corporation and changed its name to Morris Business Development Company in March 2007. Morris Business Development Company was founded in 1996 and is based in Redondo Beach, California.
MBDE News:
No recent news for Morris Business Development Company Inc. (OTCBB: MBDE).
D. MEDICAL INDUSTRIES LIMITED (NASDAQ: DMED)
"Up 55.90% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/DMED.php
D. Medical is a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery. D. Medical has developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient's body, using its proprietary spring-based delivery technology. D. Medical believes that its spring-based delivery mechanism is cost-effective compared to the motor and gear train mechanisms that drive competitive insulin pumps and also allows it to incorporate certain advantageous functions and design features in its insulin pumps. D. Medical has also developed an infusion set for insulin pumps and is focusing its research and development efforts on the development of next generation insulin pumps and a device that will combine a continuous glucose monitoring system and an insulin pump on the same patch.
DMED News:
May 14 - D. Medical Signs First Worldwide OEM Agreement for Spring Universal™ Detach Detect Infusion Sets
D. Medical Industries Ltd. (Nasdaq: DMED) ("D. Medical" or the "Company"), announced that its subsidiaries, Spring Health Solutions Ltd. and Spring Set Health Solutions Ltd. (collectively, "Spring Health"), have entered into an original equipment manufacturer ("OEM") agreement (the "Agreement") with Twobiens Ltd., a leading South Korea-based supplier of diabetes treatment and drug delivery products, for the worldwide distribution of its Spring Universal(TM) Detach Detect Infusion Sets under Twobiens' private label.
The Agreement is for a term of three years and contains annual sales targets and minimum order quantities estimated at a total of US$5 Million. Twobiens shall be responsible for all costs and expenses incurred by it in the performance of its duties and responsibilities under the Agreement. In addition, the Company and Spring Health retain all of their proprietary and intellectual property rights.
Efri Argaman, D. Medical's Chief executive Officer, commented, "In parallel with managing the ongoing strategic restructuring process that was announced in March 2012, we are pursuing major OEM and other high volume sales opportunities, such as this exciting new partnership with Twobiens. This partnership is expected to increase the pace of bringing our novel technology to more people with diabetes. At the same time, we continue to explore various licensing and other opportunities designed to maximize shareholder value."
Kyu Dong Choi, President and CEO of Twobiens, said, "Patient interest in ground-breaking new products for diabetes management, like the Spring Universal Infusion Set, is increasing rapidly and we are very pleased to be able to market and sell it under our private label. We are also impressed by D. Medical's strong record of achievement in clinical and commercial product innovation. Indeed, we are now working together to examine ways that we might potentially extend our commercial relationship beyond Spring Universal."
ABOUT THE SPRING UNIVERSAL INFUSION SET
The Spring Universal Infusion Set is compatible with most insulin pumps currently available on the market. Going beyond the minimum requirements of subcutaneous drug delivery, the Spring Universal offers best-in-class features such as a hidden, auto-retractable needle, 360 degree connector, and smallest one-click, all-in-one inserter.
The core of the Spring Universal Infusion Set is the proprietary Detach-Detect mechanism. In the case, the base of the infusion set detaches from the user's body, a blocking mechanism is triggered which, in turn, creates an occlusion. This evokes an occlusion alarm in an insulin pump. This unique feature enables exceptional reliability for continuously controlled and monitored insulin delivery, providing additional safety and peace of mind - especially for athletes and the parents of pediatric patients.
ABOUT TWOBIENS
Twobiens is specialized in comprehensive diabetes medical devices and disposables, and is committed to improve the quality of lives of people with diabetes. Twobiens supplies various kinds of insulin pumps and disposables such as infusion sets, insulin pen needles and insulin syringes.
EGPI FIRECREEK INCORPORATED (OTCBB: EFIR)
"Up 50.00% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/EFIR.php
EGPI Firecreek, Inc.'s business and acquisition strategy is focused on producing oil and gas. The Company puts emphasis on acquiring existing fields with proven reserves or by the rehabilitation of oilfields with potentially high throughput. Through its wholly owned subsidiary Energy Producers, Inc., it acquires resource properties and inventories. Through its wholly owned subsidiary Chanwest Resources, LLC it operates as an oil and gas service business. EGPI Firecreek, Inc. is also planning to expand into producing energy through alternative energy sources through their recently acquired Arctic Solar Engineering subsidiary.
EFIR News:
No recent news for EGPI Firecreek, Inc. (OTCBB: EFIR).
GUARD DOG INCORPORATED (OTC: GRDO)
"Up 33.33% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/GRDO.php
Guard Dog, Inc. is rapidly accelerating to become an industry leader in the rapidly growing field of Identity Theft Protection. The company strives to serve the growing needs of consumers throughout the United States. Guard Dog, Inc. is an aggregator and supplier of a broad spectrum of services similar to that of other industry leaders including LifeLock. However, in addition to offering a similar suite of services to that of competitors, Guard Dog, Inc. provides downloadable applications, which will notify a customer through a computer alert notification in the event of any identity theft red flags become triggered.
GRDO News:
No recent news for Guard Dog Inc. (OTC: GRDO).
DUTCH GOLD RESOURCES (OTC: DGRI)
"Up 48.00% on Monday"
Detailed Quote: http://www.otcpicks.com/quotes/DGRI.php
Dutch Gold Resources, Inc. is engaged in the acquisition and development of gold properties in North America. The company's strategy is to focus on overlooked resources that can be quickly and cost-efficiently brought into production, and to seek out potentially significant exploration targets in high value geographies. The Basin Gulch project Montana, and the Gold Bug Mine in Oregon comprise the Company's current portfolio. The DGRI management team is composed of seasoned professionals with decades of experience in geology, and in mergers and acquisitions, as well as corporate finance.
DGRI News:
May 11 - Dutch Gold Resources, Inc. Confirms Press Conference at NASDAQ MarketSite, Announces Follow Up Conference Call to Discuss Corporate Developments Marketwire
Dutch Gold Resources, Inc. (OTC: DGRI) (the "Company") announced that it has scheduled a press conference to announce important new corporate developments and an expansion of its business strategy. The webcast will be held May 17, 2012, 1:15 EDT from NASDAQ MarketSite 4 Times Square New York, NY.
The Company will host an Investor Conference Call on May 18, 2012 at 1.15PM EDT. The purpose of this call will be to provide a Question and Answer forum for our investors.
The video webcast streamed live from MarketSite. You may follow the webcast at the URL is as follows: http://ir.stockpr.com/dutchgold/presentations. A link will be provided on Thursday, May 17, 2012.
The May 18th Investor Conference call can be entered by dialing: (712) 432-1001 (U.S. and International callers) and entering access number 492518080#. The call will be recorded and may be accessed by using the same dial-in number and access code one hour after the call. A webcast will also be archived on the Company's website and a telephone replay of the call will be available through midnight, June 18, 2012, using the same dial-in instructions.
The Company intends to discuss important developments of its business plan consistent with the Company's stated goal of developing cash flow, as outlined in its last Investor Conference Call. A summary of that call may be found on the Company website.
|
